Enschede, Netherlands

Meint De Boer

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Nanopass Technologies Ltd., Nanopass Ltd.. Active years: 2003-2013.

USPTO Granted Patents = 5 

% Patents Active = 40.0


 

Average Co-Inventor Count = 5.2

ph-index = 5

Forward Citations = 355(Granted Patents)


Company Filing History:


Years Active: 2003-2013

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: Biography of Meint De Boer

Introduction

Meint De Boer is a notable inventor based in Enschede, Netherlands. He has made significant contributions to the field of microneedle technology, holding a total of five patents. His innovative work has the potential to impact various applications in medicine and biotechnology.

Latest Patents

One of his latest patents is titled "Microneedle structure and production method therefor." This patent describes a method for processing a wafer to create a plurality of hollow microneedles that project from a substrate. The process involves forming recessed features using a dry etching technique, followed by coating the internal surfaces with a protective layer. An anisotropic wet etching process is then applied to remove material from outside the included areas, leaving projecting features within each area. Finally, the protective layer is removed to reveal the microneedles.

Career Highlights

Throughout his career, Meint De Boer has worked with various companies, including Nanopass Technologies Ltd. and Nanopass Ltd. His experience in these organizations has allowed him to refine his skills and contribute to advancements in microneedle technology.

Collaborations

Meint has collaborated with notable individuals in his field, including Yehoshua Yeshurun and Meir Hefetz. These collaborations have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…